Correlation Between Evogene and Syros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Evogene and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evogene and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evogene and Syros Pharmaceuticals, you can compare the effects of market volatilities on Evogene and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evogene with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evogene and Syros Pharmaceuticals.
Diversification Opportunities for Evogene and Syros Pharmaceuticals
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Evogene and Syros is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and Evogene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evogene are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of Evogene i.e., Evogene and Syros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Evogene and Syros Pharmaceuticals
Given the investment horizon of 90 days Evogene is expected to generate 0.18 times more return on investment than Syros Pharmaceuticals. However, Evogene is 5.48 times less risky than Syros Pharmaceuticals. It trades about -0.36 of its potential returns per unit of risk. Syros Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest 241.00 in Evogene on August 30, 2024 and sell it today you would lose (72.30) from holding Evogene or give up 30.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evogene vs. Syros Pharmaceuticals
Performance |
| Timeline |
| Evogene |
| Syros Pharmaceuticals |
Evogene and Syros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evogene and Syros Pharmaceuticals
The main advantage of trading using opposite Evogene and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evogene position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.| Evogene vs. Arcus Biosciences | Evogene vs. Fate Therapeutics | Evogene vs. Pluri Inc | Evogene vs. Lexaria Bioscience Corp |
| Syros Pharmaceuticals vs. Surrozen | Syros Pharmaceuticals vs. Bolt Biotherapeutics | Syros Pharmaceuticals vs. Larimar Therapeutics | Syros Pharmaceuticals vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |